Summarized by Masters of Longevity from Hevolution Foundation.
Hevolution Foundation and Dolby Family Ventures joined Vandria’s second Series A closing, bringing the total round to $30.7 million (CHF 28.3 million).
Key Takeaways
- The reported amount is the total Series A, not the second closing alone.
- The financing supported planned first-in-human testing of mitophagy candidate VNA-318.
- Further efficacy studies depended on Phase 1 progress and regulatory approvals.
